Understanding the Oligonucleotide Landscape
Though attracting growing interest in drug development circles, oligonucleotide-based therapeutics present manufacturers with specific processing and characterization challenges.
Read our latest article published in The Medicine Maker here
Understanding the Oligonucleotide Landscape
